Artificial Intelligence-Guided Relaxation Interventions for Reducing Anxiety and Enhancing Coping Strategies in Patients Undergoing Hemodialysis

What this Trial Is About

Researchers are investigating whether an artificial intelligence (AI)-guided relaxation program can help reduce anxiety and improve coping skills in adults undergoing maintenance hemodialysis. This study focuses on patients with end-stage renal disease who often experience significant stress and discomfort during dialysis. The trial uses a randomized controlled design to compare patient well-being before and after using the AI intervention against standard care. Sixty adult patients will be randomly assigned to one of two groups: an intervention group receiving AI-driven relaxation sessions during their dialysis treatments, and a control group receiving routine nursing care without AI. The AI program offers personalized relaxation techniques like deep breathing, progressive muscle relaxation, guided imagery, and mindfulness through a digital platform with headphones. These sessions last 20 to 30 minutes, occurring two to three times weekly over four to six weeks. Participants will be assessed before and after the intervention using standardized questionnaires measuring anxiety, depression, coping strategies, and perceived relaxation. The study also includes interviews with participants in the intervention group to explore their experiences with the AI technology. Data collection aligns with the 4-6 week treatment period, aiming to understand both quantitative changes and personal impacts. Safety and adherence are monitored throughout the study.

AI-Guided Relaxation for Hemodialysis Anxiety